Investor Overview

Synta Overview

Our mission at Synta is to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. We aim to create the best place for the best people to create breakthrough drugs that change medical... More >>

Recent NewsMore >>
09/04/14Synta Reports Inducement Grant to New Chief Executive Officer
LEXINGTON, Mass.--(BUSINESS WIRE)--Sep. 4, 2014-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced the grant of an inducement award to its newly appointed Chief Executive Officer, Anne Whitaker. The award was approved by the Board's Compensation Committee and ratified by the full Board on August 1, 2014 as an inducement material to Ms. Whitaker’s entering into employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). The aw... 
Printer Friendly Version
08/06/14Synta Names Anne Whitaker Chief Executive Officer
LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 6, 2014-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that Anne Whitaker will join the Company as President, Chief Executive Officer and a member of the Company’s Board of Directors effective September 2, 2014. Ms. Whitaker has more than 20 years of experience in the pharmaceutical industry, principally at GlaxoSmithKline and Sanofi including, most recently, the role of President, North America ... 
Printer Friendly Version
08/06/14Synta Reports Second Quarter Financial Results and Provides Corporate Update
Webcast and Conference Call Today, August 6, at 10:00 AM ET LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 6, 2014-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today reported financial results for the second quarter ended June 30, 2014 and provided an update on recent corporate events. “Since the beginning of this year, ganetespib has reached several important clinical milestones across studies and cancer types, including encouraging results ... 
Printer Friendly Version
07/30/14Synta to Host Conference Call and Webcast of Second Quarter 2014 Financial Results on August 6, 2014
LEXINGTON, Mass.--(BUSINESS WIRE)--Jul. 30, 2014-- Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it will report its second quarter 2014 financial results on Wednesday, August 6, 2014, before market open. Following the announcement, management will host a conference call and webcast at 10:00 a.m. ET that morning to discuss the second quarter results and provide operational updates. The conference call can be access... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Stock Quote
SNTA (Common)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 0.07 (2.24%)
Data as of 10/21/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Synta 2013 Form 10-K